MedPath

Impact of tacrolimus 0.03% eye drop on dry eye symptoms

Not Applicable
Conditions
dry eye syndrome.
Other disorders of lacrimal gland
Registration Number
IRCT2016102430485N1
Lead Sponsor
Vice Chancellor for research of Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

patients aged above 50 years old with cataract planned for phacoemulsification.
Exclusion criteria: history of an ocular trauma or any chemical or thermal burn; allergy to any of the study medications; history of any condition that may cause dry eye; systemic connective tissue disease; corneal contact lens wear; any active ocular disease; uncontrolled systemic disease; a history of ocular allergic disease; prior refractive surgery or any ocular surgery; history of any medication which may induce dry eye; any history of inflammatory or infectious ocular disease; diagnosis of dry eye syndrome by Schirmer 1 test <10 mm or tear film break up time <10 seconds.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Eye problems in doing daily jobs. Timepoint: Before intervention and one month after treatment. Method of measurement: Ocular Surface Disease Index questionnaire.;Tear break up time. Timepoint: Before intervention and one month after treatment. Method of measurement: In seconds, With timer and Slit Lamp.;Tear production. Timepoint: Before intervention and one month after treatment. Method of measurement: Schirmer 1 test in millimeters.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath